Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details
Acute Care at Home
Acute Care at Home

0 review

Categories

Solutions

Description

Product Description:

Eligible patients are discharged to the myLaurel clinical team from the hospital early, opening bed capacity and improving throughput across the ED, Observation, Inpatient, Post-Surgical and Post-Acute areas. myLaurel treats the patient in the home and virtually over the next 7- 30 days to ensure high-quality outcomes and no readmission for the same or related condition. The patient is then scheduled back into the health system network, typically through primary care, to maintain continuity of care with the health system. If the patient enters the ED at any point while under myLaurel’s care, the health system does not pay myLaurel.

About myLaurel:

myLaurel™ was founded on the idea that the best way to deliver high-quality care is to deliver it in the home. We are the leader in home-based acute care tailored to the needs of frail, elderly, or complex patients. Our innovative models reduce avoidable hospital admissions and readmissions while improving throughput, shortening length of stay, and maintaining high standards of care, safety, and satisfaction.  

Utilizing an interdisciplinary team of telehealth physicians, in-home paramedics, and RN care managers, myLaurel ensures patients avoid the conventional acute care journey from ER to admission to post-acute care. The innovative care model creates dramatic cost savings, helps patients prevent hospital-acquired conditions, and radically improves the patient and caregiver experience.

Product Description:
Corrie is an evidenced-based digital health program that has been evaluated in the Myocardial Infarction, COmbined-device, Recovery Enhancement MiCORE Study (ClinicalTrials.gov Identifier: NCT03760796) at 4 hospitals and was shown to reduce risk of 30-day readmission, improve patient experience, and create cost-savings. Corrie is a prescription strength virtual care program that consists of a smartphone application paired with a smartwatch and bluetooth blood pressure cuff. Key features of Corrie include 1) tracking and reminders for cardiac medications; 2) monitoring BP with an Food and Drug Administration–approved wireless BP cuff; 3) promoting exercise, physical activity, step tracking, via a smartwatch 4) providing peer-reviewed educational videos and articles on diet, medications, and how to prevent CVD/hypertension/dyslipidemia/glucose intolerance through lifestyle modification; 5) reviewing patient reported data through a check-up feature that allows patients to send health summary reports of physical activity and vitals to clinicians; and 6) connecting with providers and addressing social determinants of health services to optimize guideline-directed evidence-based care. In the era of COVID-19 and beyond the Corrie program is a technology-enhanced patient experience that provides the fundamental care components, data collection, and support for optimal cardiac recovery.
About Corrie Health:
Helping to solve one of the largest problems facing global healthcare, we are fortunate to have a Johns Hopkins team that has been intensively working in digital health technology and leading the world in its development, evaluation, and integration with healthcare delivery. The Corrie Health® Platform is the culmination of 4 years of cross-university teamwork and research at Johns Hopkins to improve evidenced-based care at Johns Hopkins and across the country. Corrie (“Cor” is Latin for heart) was created by an interdisciplinary team of Johns Hopkins cardiologists, internists, nurses, engineers, Armstrong patient safety and quality improvement leaders, and behavioral health specialists, in partnership with Apple designers and patients to improve cardiovascular prevention. Corrie’s intuitive user interface was built in close collaboration with engineers and designers at Apple to empower patients in self-management, and is now available on Android as well. At its core, the Corrie Health® Digital Platform is a smartphone application driving self-management of medications, vitals, activity, and care coordination connected to cooperative sensors including a smartwatch and wireless blood pressure cuff. The Corrie Cloud securely stores data metrics and vitals from the app to make them accessible within the upcoming Corrie Portal where real-time data analysis is performed to detect digital biomarkers and activate external actions via the Corrie Decision Engine. This will trigger near real-time alerts on Corrie Care for providers, care companions, and pharmacists so they can respond in a timely fashion to risk signals detected from changes in the patient’s clinical status. Corrie Health® is the intersection of enhanced patient engagement, data analytics targeting digital biomarkers, and remote monitoring working together to reduce hospital readmissions and promote personalized, cost-effective care. The Corrie Care app and the Corrie Portal will initially be available as a technology preview and grow in features as we continue to gather feedback. Corrie Health® offers major value to Hospitals by providing a clinically validated digital health platform deployed in the acute care setting. The Corrie Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) Study examined whether using the Corrie Health Digital Platform could reduce all-cause, unplanned 30-day hospital readmissions and related healthcare costs for acute myocardial infarction (AMI) patients as compared to a historical comparison group. The study was carried out at two leading academic hospitals, Massachusetts General and Johns Hopkins, and two community hospitals, Reading Health System and Johns Hopkins Bayview Medical Center. Corrie was the intervention in the study that served as a self-management digital health program to support guideline-directed care including: 1) medication adherence, 2) vitals monitoring, 3) peer-reviewed education, 4) physical activity, 5) follow-up appointment tracking, and 6) connection with clinicians. From October 1, 2016 to April 14, 2019, 200 English-speaking adults diagnosed with Type I AMI who owned a smartphone were enrolled across four hospitals in the United States. Patients received Corrie as early as possible in their hospitalization and were encouraged to use it during the hospitalization through 30 days post-hospital discharge. The historical comparison group consisted of 864 adults who were admitted between October 2015-2016 with STEMI or NSTEMI from these study hospitals. The final results are under review but showed: ● Major reduction in risk of 30-day all cause readmission compared to the historical control group ● Significant cost savings per patient compared to standard of care alone for a hospital and increased quality of life years. [Based on the assumption that Corrie costs $3,000 per patient. Cost savings is per hospital based on savings from readmission reduction] ● Majority of Corrie users felt confident managing medications, follow-up appointments, and home care at 30 days

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Use Cases

Description:

Navigating complex health issues while balancing the demands of daily life can be incredibly challenging. For Chelsea F., a 34-year-old woman with a history of congenital duodenal atresia, gastroparesis, gluten intolerance, and multiple food allergies, this reality hit hard when a series of severe health complications led her to seek help in the emergency room.

The Clinical Challenge

Chelsea's story began with a frustrating cycle of frequent ER visits. Over the span of just one month, she was admitted to the emergency room seven times due to persistent and severe nausea and vomiting. Alongside these symptoms, she experienced worrying neurological issues, including paresthesia (tingling or numbness), dizziness, weakness, difficulty walking, and visual impairment.

Upon admission to the hospital, an endoscopy was performed, which yielded no significant findings. Despite this, Chelsea's condition was severe enough to necessitate a thorough evaluation and treatment plan. The medical team administered a combination of intravenous medications: droperidol for nausea, famotidine for stomach acid reduction, magnesium for electrolyte balance, and normal saline for hydration.

“myLaurel was a lifesaver,” Chelsea recounts. “I was supposed to stay in the hospital for three more days for a certain IV treatment, but because of myLaurel, I was able to go home and spend precious time with my five-year-old daughter.”

— Chelsea; patient, mom

A Turning Point: Neurological Insights

The breakthrough came when the neurology team identified Chelsea's neurological symptoms were likely due to deficiencies in essential B vitamins, specifically thiamine (vitamin B1) and niacin (vitamin B3). This revelation pointed to a crucial aspect of her treatment: aggressive vitamin repletion. 

Transitioning to Home

Despite the promising new treatment plan, Chelsea faced a dilemma. The thought of spending additional days in the hospital beyond her almost two-week stay was daunting, particularly as she had a young daughter at home who was only able to visit her once while she was in inpatient treatment. Fortunately, Ochsner Health called on their home-care partner, myLaurel, which provided a solution allowing Chelsea to early discharge from the hospital and continue her treatment from the comfort of her home.

The myLaurel Experience

Chelsea’s experience with myLaurel was marked by both convenience and quality care. The home care team visited Chelsea’s home for intravenous treatments over the course of three days, with the first treatment beginning the day after she was discharged. Chelsea was prescribed a regimen of thiamine, starting with 500 mg IV three times a day for two days, then a reduced dosage of 250 mg IV daily for five days, and then 100 mg orally daily for the foreseeable future.

“The service was professional and caring,” Chelsea notes. “The in-home providers were consummate professionals, friendly and efficient, and the treatments were completed quickly—usually in about 30 to 45 minutes. They were accompanied by a physician over telehealth.”

“I was very impressed by how quickly the physicians actually dug into my history and understood it before they started talking to me.” 

The flexibility of receiving care at home allowed Chelsea to focus on her recovery and family life. “Being at home made a huge difference,” she says. “I didn’t have to stay in the hospital an additional three days for a treatment that took a half-hour and could be present for my daughter, who was about to start kindergarten. I’m doing better, little by little.” 

Final Thoughts

Chelsea’s journey underscores home-based care's profound impact on a patient's quality of life. For patients like Chelsea, balancing complex medical needs with family responsibilities can be daunting. MyLaurel’s ability to deliver high-quality care at home offers a vital alternative, ensuring that patients receive the treatment they need while maintaining their daily routines and family connections.

“I’m not one to let strangers in, but the people I met with were all very nice and very kind, and I had no problem letting them in to help me. The myLaurel team called for my first treatment and then called ahead over the next two days when they were on their way.”  

As Chelsea continues her recovery, with follow-up appointments to monitor her vitamin levels and neurological health, she remains grateful for the support and flexibility provided by myLaurel. Her story is a testament to the transformative power of home-based care in managing chronic and complex health conditions.

Conclusion

For those navigating similar health challenges, Chelsea’s story highlights the benefits of exploring home care options. myLaurel offers a compassionate and practical solution for patients and their families by bridging the gap between hospital-based treatments and home life.

Chelsea shares a tearful final thought: "It frees you up to live the rest of your life. The freedom to be at home and still live your life was a humongous plus to this whole experience.”  

Pediatric use cases:

None provided

Users:

18+ patients, within service areas, partnered health system patients. 

Description:

None provided

Pediatric use cases:

None provided

Users:

None provided

EHR Integrations

Integrations:

Acute care EMR, Ambulatory EMR

EMR Integration & Relevant Hardware:

Recommended, but not required

EMRs Supported:

Epic, Cerner, Meditech, Allscripts, NextGen, athena, GE, eClinicalWorks, McKesson, Other, Allscripts/Eclipsys, Athenahealth, Azalea Health/Prognosis, CPSI, Evident, Healthland, MEDHOST, MedWorx, QuadraMed, Self-developed, Would prefer not to disclose, Point Click Care

Hardware Compatibility:

None provided

Integrations:

None provided

EMR Integration & Relevant Hardware:

None provided

EMRs Supported:

None provided

Hardware Compatibility:

None provided

Client Types

None provided

Awards

edit-media
No awards image

Differentiators

Differentiators vs EHR Functionality:

Can work with any external EHR. 

Differentiators vs Competitors:

Why we're unique:

Flexibility:

The myLaurel care model is tailored and based on patient need allowing us to match visit frequency and intensity.

Expansion of your care with network integrity:

All patients we see are direct referrals from the hospitals we serve. We are fully integrated into your clinical teams, operating off the same playbook. Our primary goal is to provide your patients a soft landing and timely access to post-acute care and then tuck them back into your system.

Clinical expertise & capabilities:

Uniquely built to care for patients in their home.   

myLaurel possesses a broad scope of capabilities, including real time diagnostics (e.g blood tests, 12-lead EKG), therapeutics (e.g IV, IM medications, oxygen and IV fluid via our in-home care team), labs/mobile imaging, prescriptions via tele support, and care coordination - with a supportive hand-off to your home health and/or primary care team. 

Complex patient care:

Elderly, frail, complex, comorbid - this is our area of expertise. 

Scale: 

-Designed to help you serve a larger funnel of patients versus other post-acute models - with the flexibility in co-design of who we treat 

-Partnering with myLaurel enables expanded capacity and efficiencies immediately without the extensive resources, time, overhead, training, and logistic configuration of facility planning or pursuing your own in-home post-acute model.  

Speed to value turn-key implementation: 

Clients are up and running in 90 days or less. We bring the resources, diagnostics, formulary, supplies, and operations bundled and ready to execute, with a single internal champion needed from your side to get going.  

Outcomes-based contracting:

We put our fees at risk for readmission while under our care, aligning our clinical team more closely with our hospital partners.  

Did we mention the 3:1+ ROI? 

Differentiators vs EHR Functionality:

None provided

Differentiators vs Competitors:

None provided

Keywords

Images

1 of 1

edit-media
myLaurel City 1 (2).png

No images provided

Videos

No videos provided

No videos provided

Downloads

media thumbnail
myLaurel Acute Care Overview 2024 (3).pdf

No content provided

Alternatives

Company Details

Founded in 2016

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top